Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
3.010
+0.170 (5.99%)
Nov 21, 2024, 1:59 PM EST - Market open
Repare Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Repare Therapeutics stock has a target of 10, which predicts an increase of 232.23% from the current stock price of 3.01.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for RPTX is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +232.23% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +232.23% | Oct 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +232.23% | Sep 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +232.23% | Sep 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +232.23% | Jun 5, 2024 |
Financial Forecast
Revenue This Year
57.96M
from 51.13M
Increased by 13.36%
Revenue Next Year
5.99M
from 57.96M
Decreased by -89.67%
EPS This Year
-2.25
from -2.23
EPS Next Year
-3.26
from -2.25
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 66.7M | 21.0M | 103.6M | ||
| Avg | 58.0M | 6.0M | 35.9M | ||
| Low | 52.4M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 30.4% | -63.8% | 1,629.6% | ||
| Avg | 13.4% | -89.7% | 498.9% | ||
| Low | 2.5% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.04 | -2.84 | -1.69 | ||
| Avg | -2.25 | -3.26 | -2.74 | ||
| Low | -2.52 | -3.67 | -3.70 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.